Market watch: Trends in pharmaceutical company R & D spending: 2005 – 2015

Nature Reviews Drug Discovery 16, 376 (2017). doi:10.1038/nrd.2017.81 Authors: Richa Dixit & Frank S. David Pharmaceutical industry trade groups commonly claim that growing revenues (supported by premium prices) are required to drive innovative R&D, whereas critics maintain that drug companies' outsized returns mainly support corporate infrastructures, fuel marketing budgets and enrich investors. In fact, both arguments are incompletely supported by
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research